NUTRIBAND INC. Revenue from Contract with Customer, Including Assessed Tax
NUTRIBAND INC. (NTRB) reported Revenue from Contract with Customer, Including Assessed Tax of $437.51 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-04.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-09-04
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-07-31 was $437.51K, a 29.71% decline year-over-year.
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-04-30 was $433.40K, a 35.06% decline year-over-year.
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for the quarter ending 2026-01-31 was $400.71K, a 37.62% decline year-over-year.
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for the quarter ending 2025-10-31 was $346.06K, a 46.41% decline year-over-year.
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for fiscal 2026 was $2.04M, a 4.81% decline from fiscal 2025.
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for fiscal 2025 was $2.14M, a 2.60% increase from fiscal 2024.
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for fiscal 2024 was $2.09M, a 0.27% increase from fiscal 2023.
- NUTRIBAND INC. revenue from contract with customer, including assessed tax for fiscal 2023 was $2.08M, a 76.30% increase from fiscal 2022.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month | Revenue from Contract with Customer, Including Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-07-31 | $437.51K 10-Q · filed 2026-09-04 | $870.91K 10-Q · filed 2026-09-04 | $1.27M derived: sum of 3 quarters · filed 2026-09-04 | $1.62M derived: sum of 4 quarters · filed 2026-09-04 | ||
| 2026-04-30 | $433.40K 10-Q · filed 2026-06-11 | $834.11K derived: sum of 2 quarters · filed 2026-06-11 | $1.18M derived: sum of 3 quarters · filed 2026-06-11 | $1.80M derived: sum of 4 quarters · filed 2026-09-04 | ||
| 2026-01-31 | $400.71K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-29 | $746.77K derived: sum of 2 quarters · filed 2026-04-29 | $1.37M derived: sum of 3 quarters · filed 2026-09-04 | $2.04M 10-K · filed 2026-04-29 | ||
| 2025-10-31 | $346.06K 10-Q · filed 2025-12-11 | $968.51K derived: sum of 2 quarters · filed 2026-09-04 | $1.64M 10-Q · filed 2025-12-11 | $2.28M derived: sum of 4 quarters · filed 2026-09-04 | ||
| 2025-07-31 | $622.45K 10-Q · filed 2026-09-04 | $1.29M 10-Q · filed 2026-09-04 | $1.93M derived: sum of 3 quarters · filed 2026-09-04 | $2.58M derived: sum of 4 quarters · filed 2026-09-04 | ||
| 2025-04-30 | $667.43K 10-Q · filed 2026-06-11 | $1.31M derived: sum of 2 quarters · filed 2026-06-11 | $1.96M derived: sum of 3 quarters · filed 2026-06-11 | $2.40M derived: sum of 4 quarters · filed 2026-06-11 | ||
| 2025-01-31 | $642.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-29 | $1.29M derived: sum of 2 quarters · filed 2026-04-29 | $1.73M derived: sum of 3 quarters · filed 2026-04-29 | $2.14M 10-K · filed 2026-04-29 | ||
| 2024-10-31 | $645.80K 10-Q · filed 2025-12-11 | $1.09M derived: sum of 2 quarters · filed 2025-12-11 | $1.50M 10-Q · filed 2025-12-11 | $2.02M derived: sum of 4 quarters · filed 2025-12-11 | ||
| 2024-07-31 | $442.83K 10-Q · filed 2025-09-09 | $851.36K 10-Q · filed 2025-09-09 | $1.38M derived: sum of 3 quarters · filed 2025-09-09 | $1.80M derived: sum of 4 quarters · filed 2025-09-09 | ||
| 2024-04-30 | $408.53K 10-Q · filed 2025-05-30 | $933.14K derived: sum of 2 quarters · filed 2025-05-30 | $1.36M derived: sum of 3 quarters · filed 2025-05-30 | $2.02M derived: sum of 4 quarters · filed 2025-05-30 | ||
| 2024-01-31 | $524.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-28 | $952.45K derived: sum of 2 quarters · filed 2025-04-28 | $1.61M derived: sum of 3 quarters · filed 2025-04-28 | $2.09M 10-K · filed 2025-04-28 | ||
| 2023-10-31 | $427.84K 10-Q · filed 2024-12-04 | $1.08M derived: sum of 2 quarters · filed 2024-12-04 | $1.56M 10-Q · filed 2024-12-04 | $2.09M derived: sum of 4 quarters · filed 2024-12-04 | ||
| 2023-07-31 | $655.93K 10-Q · filed 2024-09-03 | $655.93K 10-Q · filed 2023-09-11 | $1.13M 10-Q · filed 2024-09-03 | $1.66M derived: sum of 3 quarters · filed 2024-09-03 | $2.28M derived: sum of 4 quarters · filed 2024-09-03 | |
| 2023-04-30 | $476.93K 10-Q · filed 2024-05-31 | $1.00M derived: sum of 2 quarters · filed 2024-05-31 | $1.62M derived: sum of 3 quarters · filed 2024-05-31 | $2.08M derived: sum of 4 quarters · filed 2024-05-31 | ||
| 2023-01-31 | $527.63K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-01 | $1.15M derived: sum of 2 quarters · filed 2024-05-01 | $1.60M derived: sum of 3 quarters · filed 2024-05-01 | $2.08M 10-K · filed 2024-05-01 | $1.79M 10-K · filed 2023-04-26 | |
| 2022-10-31 | $618.00K 10-Q · filed 2023-12-13 | $1.07M derived: sum of 2 quarters · filed 2023-12-13 | $1.55M 10-Q · filed 2023-12-13 | |||
| 2022-07-31 | $456.15K 10-Q · filed 2023-09-11 | $934.07K 10-Q · filed 2023-09-11 | ||||
| 2022-04-30 | $477.92K 10-Q · filed 2023-06-09 | |||||
| 2022-01-31 | $1.18M 10-K · filed 2023-04-26 | |||||
| 2021-01-31 | $737.52K 10-K · filed 2022-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |